MTCH vs PYXS · P/E 13, rev $3.48B vs rev $2.8M
Match Group Inc (MTCH) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
MTCH currently screens at market cap $8.24B and trailing P/E 13.5. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the MTCH and PYXS stock pages for the full models.
Not investment advice.